Lithium vs haloperidol
It is very uncertain whether lithium changes acceptability: total withdrawals compared with haloperidol (very low certainty).
- OR 0.29 [0.03, 3.12]1 study · 30 participantsVery low
It is very uncertain whether lithium changes acceptability: total withdrawals compared with haloperidol (very low certainty).
It is very uncertain whether lithium changes acceptability: total withdrawals compared with zuclopenthixol (very low certainty).
Lithium probably leads to higher acceptability: total withdrawals compared with risperidone (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with aripiprazole (moderate certainty).
Lithium showed no clear difference in acceptability: total withdrawals compared with topiramate (high certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Lithium showed no clear difference in acceptability: total withdrawals compared with all antimanic agents (high certainty).
Valproate showed no clear difference in dropout rate ‐ All‐cause At 4‐6 weeks (secondary acceptability… compared with placebo (low certainty).
Valproate showed no clear difference in dropout rate ‐ All‐cause At 2‐4 weeks (secondary acceptability… compared with lithium (moderate certainty).
It is very uncertain whether valproate changes dropout rate ‐ All‐cause At 8 weeks (secondary acceptability outcome) compared with lithium (very low certainty).
Valproate showed no clear difference in dropout rate ‐ All‐cause At 3‐12 weeks (secondary acceptability… compared with olanzapine (high certainty).
Valproate showed no clear difference in dropout rate ‐ All‐cause (secondary acceptability outcome) At 5 ‐ 12… compared with risperidone (low certainty).
Valproate showed no clear difference in dropout rate ‐ All‐cause 3‐8 weeks (secondary acceptability outcome) compared with placebo (moderate certainty).
It is very uncertain whether summary of findings: Specialist inpatient care for weight restoration changes acceptability: number of participants who completed treatment (at… compared with active outpatient or combination brief hospital/outpatient care (very low certainty).
Stand‐alone couple or family therapy showed no clear difference in treatment dropout (treatment acceptability) compared with other structured or non‐specific intervention (low certainty).
Adjunctive couple or family therapy showed no clear difference in treatment dropout (treatment acceptability) compared with structured or non‐specific individual therapy alone (low certainty).
Stand‐alone couple or family therapy showed no clear difference in treatment dropout (treatment acceptability) compared with no treatment (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether ECT plus standard care changes satisfaction and acceptability of treatment (medium term) ‐ leaving… compared with standard care (very low certainty).